Table 2.
Risk of cardiovascular events, motor vehicle collision, lifetime costs, life expectancy and quality adjusted life expectancy associated with CPAP treatment in a 50-year-old male with moderate-to-severe OSA
| 10 years |
Lifetime |
|||
|---|---|---|---|---|
| No Treatment | Treatment | No Treatment | Treatment | |
| Risk of MI | 11.38% | 5.81% | 56.25% | 38.87% |
| Risk of Stroke | 3.01% | 2.07% | 14.90% | 14.64% |
| Avg. no. of MVC | 0.724 | 0.352 | 1.781 | 0.939 |
| Risk of fatal MVC | 0.57% | 0.28% | 1.41% | 0.74% |
| Undiscounted | ||||
| Cost | $81,743 | $92,442 | $359,919 | $408,845 |
| Life Years | 9.473 | 9.586 | 23.332 | 25.641 |
| QALYs | 6.518 | 7.194 | 15.572 | 18.425 |
| Discounted (3%) | ||||
| Cost | $70,264 | $79,750 | $216,934 | $243,656 |
| Life Years | 8.236 | 8.329 | 16.062 | 17.165 |
| QALYs | 5.672 | 6.259 | 10.814 | 12.493 |
| ICER | ||||
| $/LY-gained | $ 102,585 | $ 24,222 | ||
| $/QALY-gained | $ 16,172 | $ 15,915 | ||